- Systematic review and meta-analysis of 19 randomized controlled trials comparing anesthetic technique for hip fracture surgery in older adults.
- Spinal anesthesia was compared with general anesthesia across cardiovascular, delirium, nausea and vomiting, hypotension, pain, and functional recovery outcomes.
- No significant difference was seen for cardiovascular/cerebrovascular complications (RR 0.91, 95% CI 0.69 to 1.20) or delirium (RR 0.99, 95% CI 0.81 to 1.21).
- Spinal anesthesia was linked to better functional recovery (SMD -0.49, 95% CI -0.76 to -0.22) and lower pain scores (SMD -1.03, 95% CI -1.68 to -0.38), but few trials informed these.
Regional
Research from anesthesiology, pain and critical care journals, sourced from PubMed.
Sorted by publication date, not import date. Recent filters exclude papers with only a publication year; find those under All years.
AI-generated abstract summaries can contain errors. Verify findings against the original paper before applying them to patient care.
Last successful paper check: 16 Nov 2026 17:18 UTC.
0 newly discovered papers saved; these are not necessarily published today.
2 papers awaiting AI summaries. Summary processing had an error; paper-fetch status is separate.
Background checks run while the server is active. This does not guarantee a daily run if hosting sleeps.
2 papers awaiting AI summaries. Summary processing had an error; paper-fetch status is separate.
Background checks run while the server is active. This does not guarantee a daily run if hosting sleeps.
- This systematic review of 29 US-based regional anesthesia RCTs for total joint arthroplasty, published 2015 to 2025, included 2914 participants.
- It compared how sex, race, and ethnicity were reported in journal articles versus the corresponding ClinicalTrials.gov entries for the same trials.
- Sex was reported in 28 of 29 articles (96.6%), race in 14 (48.3%), and ethnicity in five (17.2%), while the registry captured 22 (75.9%), 12 (41.4%), and seven (24.1%).
- Trial characteristics were not significantly associated with demographic reporting, and the authors call for journals to mandate standardized reporting.
- Systematic review of 248 RCTs (2014-2024) of regional anesthesia for lower-extremity surgery, assessed for clinical utility and transparency.
- Usefulness was scored with the van 't Hooft framework: patient-centeredness was universal, with feasibility at 77.0% and context placement at 77.4%.
- Pragmatism appeared in 2.0% of trials and value-for-money analyses in 0%, while pre-registration was 39.9%, public protocols 10.1%, and raw-data sharing 1.2%.
- Transparency improved over time and correlated with clinical-utility scores (r=0.32, p<0.001), and was higher in hospital-funded, self-funded, and higher-impact journal trials.
- This systematic review compared adverse event data for interventional regional anesthesia trials registered on ClinicalTrials.gov with trials' peer-reviewed publications.
- Four adverse event domains were extracted in duplicate, and a composite 0-7 reporting score was analyzed against regulatory status, sponsor type, and publication year.
- Substantial discrepancies in adverse event counts were found between registry and publication, and funnel plot asymmetry suggested possible underreporting in smaller studies.
- FDA-regulated trials were significantly more likely to report complete adverse event data (p<0.05), and reporting completeness rose modestly after the Final Rule, though recent-year trends were unstable.
- Systematic review and meta-analysis of 19 randomized controlled trials (n = 4,742) comparing neuraxial and general anesthesia in adults undergoing hip fracture surgery.
- Neuraxial anesthesia was compared with general anesthesia across mortality, delirium, cardiac and pulmonary complications, kidney injury, length of stay, and PONV.
- Neuraxial anesthesia was associated with lower intraoperative hypotension (RR 0.55, 95% CI 0.40-0.77), acute kidney injury (RR 0.57, 95% CI 0.38-0.84), and shorter hospital stay (MD -0.58 days, 95% CI -1.08 to -0.07).
- No significant differences were found for mortality at any time point, delirium, ACS, pneumonia, or PONV, and heterogeneity was substantial for some outcomes.
- Systematic review and meta-analysis of 104 randomized controlled trials in adults undergoing open or minimally invasive cardiothoracic surgery, published 2013 to 2024.
- Chest wall blocks and erector spinae plane blocks were compared with sham, no block, local infiltration, or neuraxial techniques.
- Chest wall blocks reduced 24-hour pain scores and opioid use versus sham or no block, and erector spinae plane blocks showed similar effects to chest wall blocks.
- The authors conclude that nerve blocks give modest pain and opioid reductions with a favorable safety profile, though adverse events were rare and inconsistently defined.
- Bayesian network meta-analysis of 22 RCTs (1,699 patients) on preventing and treating rebound pain after brachial plexus block for upper-limb surgery.
- Six interventions were compared against placebo: dexamethasone, esketamine, dexmedetomidine, liposomal bupivacaine, continuous nerve block and combined nerve block.
- Versus placebo, dexamethasone (OR 0.22, 95% CI 0.11 to 0.42), dexmedetomidine (OR 0.23, 0.08 to 0.68) and continuous nerve block (OR 0.04, 0.01 to 0.33) reduced rebound pain incidence.
- Dexamethasone and continuous block lowered 12-hour pain scores, and combined block lowered 24-hour scores; the authors call the evidence exploratory and hypothesis-generating.
- Systematic review and meta-analysis of 39 studies (n=2652) in adults with chronic non-cancer pain treated with intrathecal drug delivery.
- Twenty single-arm comparisons contributed to the pain-intensity meta-analysis at 12 months, so there was no controlled comparator.
- Pooled pain reduction from baseline was 2.64 (95% CI 2.19 to 3.08), with a 75% probability of exceeding the 2-unit MCID (95% CI 68% to 83%).
- All studies reported functional and HRQoL improvements, but adverse event reporting was inconsistent and certainty of evidence was low.
- This PROSPECT systematic review pooled 176 randomised trials and eight systematic reviews on analgesia after major oncological breast surgery.
- Recommended options include paracetamol, NSAIDs or COX-2 inhibitors, dexamethasone, several single-shot regional blocks, local infiltration analgesia, and pre- and postoperative physiotherapy.
- Gabapentin is no longer recommended because of problematic adverse effects, and continuous thoracic paravertebral block is no longer advised.
- The authors conclude that single-shot regional techniques are valuable and considered broadly equivalent to one another, though the abstract reports no pooled effect sizes.
- Systematic review and meta-analysis of 20 randomised controlled trials including 1198 adults undergoing elective shoulder surgery.
- Compared continuous with single-injection brachial plexus blocks for postoperative analgesia, using patient-reported pain and related outcomes.
- Continuous blocks gave lower resting pain at 12, 24 and 48 h (MD -1.96, -1.66 and -1.18; all p < 0.001), but pain on movement was not significantly different at 24 h (MD -2.04, 95% CI -4.26 to 0.19) or 48 h.
- The authors conclude continuous blocks improve resting pain and other patient-centred outcomes, while dynamic pain and long-term function remain uncertain.
- Systematic review and meta-analysis of eight randomised trials with 471 patients comparing intrathecal morphine with peripheral regional analgesia in elective total hip arthroplasty.
- Peripheral regional analgesia was a peripheral nerve block in six trials and local infiltration analgesia in two.
- At 24 h, resting pain did not differ, while intravenous morphine equivalent use was lower with intrathecal morphine (MD 11.38 mg, 95% CI 4.31 to 18.45).
- Pruritus was more frequent with intrathecal morphine (0.31, 95% CI 0.17 to 0.58 for peripheral analgesia), and the authors rate this evidence as high quality.
- Systematic review and network meta-analysis of 24 randomised trials including 2,130 adults undergoing surgery with single-injection peripheral nerve blocks.
- Compared eight pharmacological prophylactic strategies against control for preventing rebound pain after nerve block.
- Intravenous dexamethasone had the highest probability of reducing rebound pain incidence (SUCRA 0.91) and was judged definitely superior to control.
- Perineural dexamethasone and dexmedetomidine ranked highest for delaying rebound pain, while certainty of evidence ranged from very low to moderate.
- Cochrane systematic review and meta-analysis of 23 randomized trials comparing regional with conventional analgesia for persistent postoperative pain at 6 or 12 months.
- Three trials with 250 participants after thoracotomy compared epidural anaesthesia with conventional analgesia at 6 months.
- Epidural anaesthesia was associated with lower odds of persistent pain (OR 0.33, 95% CI 0.20-0.56).
- Paravertebral block for breast cancer surgery, from two studies with 89 participants, also favoured the block (OR 0.37, 95% CI 0.14-0.94), though the authors note small numbers and bias weaken these conclusions.
- Systematic review and meta-analysis of studies on falls after major lower-limb orthopaedic surgery with peripheral nerve blockade, including 10 studies with 4014 patients for the falls outcome.
- Five studies (four RCTs, one cohort) compared continuous lumbar plexus blockade in 631 patients with non-continuous or no blockade in 964 patients.
- Continuous lumbar plexus blockade was associated with more falls (14 vs 5 events; Peto OR 3.85, 95% CI 1.52 to 9.72, P=0.005, I²=0%), with attributable risk 1.7% and NNH 59.
- The authors concluded that continuous lumbar plexus blockade increases postoperative fall risk, but the attributable risk was within the expected probability of falls after orthopaedic surgery.